1Reddy BK, Brewster PS, Walsh T, Burket MW, Thomas WJ, et al. (2004) Randomized comparison of rapid ambulation using radial, 4 French femoral access, or femoral access with Angioseal closure. Catheter Cardiovasc Interv 62: 143–149.

2Arora N, Matheny ME, Sepke C, Resnic FS (2007) A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices. Am Heart J 153: 606-611.

3Davis C, VanRiper S, Longstreet J, Moscucci M (1997) Vascular complications of coronary interventions. Heart Lung 26: 118–127.

4Hermiller J, Simonton C, Hinohara T, Lee D, Cannon L, et al. (2005) Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization. J Invasive Cardiol 17: 504–510.

5Exaire JE, Tcheng JE, Kereiakes DJ, Kleiman NS, Applegate RJ, et al. (2005) Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaprin, glycoprotein IIb/IIIa inhibitors and clopidogrel. Catheter Cardiovasc Intern 64: 369–372.

6 Applegate RJ, Sacrinty M, Kutcher MA, Gandhi SK, Baki TT, et al. (2006) Vascular complications with newer generations of Angioseal vascular closure devices. J Interv Cardiol 19: 67–74.

7Eggebrecht H, Naber C, Woertgen U, Ringe S, Konorza TF, et al. (2003) Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device. Catheter Cardiovasc Intern. 58: 313–321.

8Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, et al. (2006) Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interv 67: 556-562.

10Samore MH, Wessolossky MA, Lewis SM, Shubrooks SJ Jr, Karchmer AW. (1997) Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol 1: 873-877.

11Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, et al. (2003) Nonvalvular cardiovascular device-related infections AHA. Circulation. 108: 2015-2031.

12Johanning JM, Franklin DP, Elmore JR, Han DC. (2001) Femoral artery infections associated with percutaneous arterial closure devices. J Vasc Surg 34: 983-985.

13Baim DS, Grossman W. (2000) Grossman’s Cardiac Catheterization Angiography and Intervention. 6th ed. Philadelphia, Pa: Lippincott Williams and Wilkins 35.

14Shea KW, Schwartz RK, Gambino AT, Marzo KP, Cunha BA. (1995) Bacteremia associated with percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn 36: 5–10.

15Wiener RS, Ong LS. (1989) Local infection after percutaneous transluminal coronary angioplasty: relation to early repuncture of ipsilateral femoral artery.Cathet Cardiovasc Diagn 16: 180–181.

16Muñoz P, Blanco JR, Rodríguez-Creixéms M, García E, Delcan JL, et al. (2001) Bloodstream infections after invasive nonsurgical cardiologic procedures. Arch Intern Med 161: 2110–2115

17O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, et al. (2002) Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51: 1-29.

18Sohail MR, Khan AH, Holmes DR Jr, Wilson WR, Steckelberg JM. et al. (2005) Infectious complications of percutaneous vascular closure devices. Mayo Clin Proc 80: 1011-1015.